Low doses of bisphenol A stimulate the proliferation of breast cancer cells via ERK1/2/ERRγ signals

Toxicology in Vitro

Volumn 30, Issue 1, 2015, Pages 521-528

  Song, Haixing ^a   Zhang, Tao ^a   Yang, Ping ^a   Li, Minhui ^a   Yang, Yuhan ^a   Wang, Yuanyuan ^a   Du, Jun ^b   Pan, Kejian ^a   Zhang, Kun ^a  

^a CHENGDU MEDICAL COLLEGE   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

BPA; Breast cancer; ERK1 2; ERR ; Proliferation

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; CYCLINE; ESTROGEN RELATED RECEPTOR GAMMA; G PROTEIN COUPLED RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN BCL 2; STEROID RECEPTOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; BENZHYDRYL DERIVATIVE; ESRRG PROTEIN, HUMAN; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR ALPHA, HUMAN; GPER PROTEIN, HUMAN; PHENOL DERIVATIVE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CONTROLLED STUDY; ERR GAMMA GENE; GENE; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TRANSLOCATION; MCF 7 CELL LINE; MITOSIS INHIBITION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; ACTIVE TRANSPORT; BREAST TUMOR; CELL PROLIFERATION; DRUG EFFECTS; FEMALE; HUMAN; MCF-7 CELL LINE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ACTIVE TRANSPORT, CELL NUCLEUS; BENZHYDRYL COMPOUNDS; BREAST NEOPLASMS; CELL PROLIFERATION; ESTROGEN RECEPTOR ALPHA; FEMALE; HUMANS; MAP KINASE SIGNALING SYSTEM; MCF-7 CELLS; PHENOLS; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 84958624491     PISSN: 08872333     EISSN: 18793177     Source Type: Journal    
DOI: 10.1016/j.tiv.2015.09.009     Document Type: Article

References (52)

1. Albanito L., Madeo A., Lappano R., Vivacqua A., Rago V., Carpino A., Oprea T.I., Prossnitz E.R., Musti A.M., Ando S., Maggiolini M. G protein-coupled receptor 30 (GPR30) mediates gene expression changes and growth response to 17beta-estradiol and selective GPR30 ligand G-1 in ovarian cancer cells. Cancer Res. 2007, 67:1859-1866.
2. Albanito L., Lappano R., Madeo A., Chimento A., Prossnitz E.R., Cappello A.R., Dolce V., Abonante S., Pezzi V., Maggiolini M. G-protein-coupled receptor 30 and estrogen receptor-alpha are involved in the proliferative effects induced by atrazine in ovarian cancer cells. Environ. Health Perspect. 2008, 116:1648-1655.
3. Arase S., Ishii K., Igarashi K., Aisaki K., Yoshio Y., Matsushima A., Shimohigashi Y., Arima K., Kanno J., Sugimura Y. Endocrine disrupter bisphenol A increases in situ estrogen production in the mouse urogenital sinus. Biol. Reprod. 2011, 84:734-742.
4. Ariazi E.A., Jordan V.C. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr. Top. Med. Chem. 2006, 6:203-215.
5. Ariazi E.A., Clark G.M., Mertz J.E. Estrogen-related receptor alpha and estrogen-related receptor gamma associate with unfavorable and favorable biomarkers, respectively, in human breast cancer. Cancer Res. 2002, 62:6510-6518.
6. Babu S., Vellore N.A., Kasibotla A.V., Dwayne H.J., Stubblefield M.A., Uppu R.M. Molecular docking of bisphenol A and its nitrated and chlorinated metabolites onto human estrogen-related receptor-gamma. Biochem. Biophys. Res. Commun. 2012, 426:215-220.
7. Bianco S., Sailland J., Vanacker J.M. ERRs and cancers: effects on metabolism and on proliferation and migration capacities. J. Steroid Biochem. Mol. Biol. 2012, 130:180-185.
8. Bouskine A., Nebout M., Brucker-Davis F., Benahmed M., Fenichel P. Low doses of bisphenol A promote human seminoma cell proliferation by activating PKA and PKG via a membrane G-protein-coupled estrogen receptor. Environ. Health Perspect. 2009, 117:1053-1058.
9. Carwile J.L., Luu H.T., Bassett L.S., Driscoll D.A., Yuan C., Chang J.Y., Ye X.Y., Calafat A.M., Michels K.B. Polycarbonate bottle use and urinary bisphenol A concentrations. Environ. Health Perspect. 2009, 117:1368-1372.
10. Cavallini A., Notarnicola M., Giannini R., Montemurro S., Lorusso D., Visconti A., Minervini F., Caruso M.G. Oestrogen receptor-related receptor alpha (ERRalpha) and oestrogen receptors (ERalpha and ERbeta) exhibit different gene expression in human colorectal tumour progression. Eur. J. Cancer 2005, 41:1487-1494.
11. Chen Z.J., Yang X.L., Liu H., Wei W., Zhang K.S., Huang H.B., Giesy J.P., Liu H.L., Du J., Wang H.S. Bisphenol A modulates colorectal cancer protein profile and promotes the metastasis via induction of epithelial to mesenchymal transitions. Arch. Toxicol. 2014, 10.1007/s00204-014-1301-z.
12. Cheung C.P., Yu S., Wong K.B., Chan L.W., Lai F.M., Wang X., Suetsugi M., Chen S., Chan F.L. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J. Clin. Endocrinol. Metab. 2005, 90:1830-1844.
13. Dairkee S.H., Seok J., Champion S., Sayeed A., Mindrinos M., Xiao W., Davis R.W., Goodson W.H. Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients. Cancer Res. 2008, 68:2076-2080.
14. Deblois G., Giguere V. Functional and physiological genomics of estrogen-related receptors (ERRs) in health and disease. Biochim. Biophys. Acta (BBA) - Mol. Basis Dis. 2011, 1812:1032-1040.
15. Deblois G., Giguere V. Oestrogen-related receptors in breast cancer: control of cellular metabolism and beyond. Nat. Rev. Cancer 2013, 13:27-36.
16. Desantis C., Ma J., Bryan L., Jemal A. Breast cancer statistics, 2013. CA Cancer J. Clin. 2014, 64:52-62.
17. Fujimoto J., Sato E. Clinical implication of estrogen-related receptor (ERR) expression in uterine endometrial cancers. J. Steroid Biochem. Mol. Biol. 2009, 116:71-75.
18. Ge L.C., Chen Z.J., Liu H., Zhang K.S., Su Q., Ma X.Y., Huang H.B., Zhao Z.D., Wang Y.Y., Giesy J.P., Du J., Wang H.S. Signaling related with biphasic effects of bisphenol A (BPA) on Sertoli cell proliferation: A comparative proteomic analysis. Biochim. Biophys. Acta 2014, 1840:2663-2673.
19. Ge L.C., Chen Z.J., Liu H.Y., Zhang K.S., Liu H., Huang H.B., Zhang G., Wong C.K., Giesy J.P., Du J., Wang H.S. Involvement of activating ERK1/2 through G protein coupled receptor 30 and estrogen receptor alpha/beta in low doses of bisphenol A promoting growth of Sertoli TM4 cells. Toxicol. Lett. 2014, 226:81-89.
20. Geens T., Aerts D., Berthot C., Bourguignon J.P., Goeyens L., Lecomte P., Maghuin-Rogister G., Pironnet A.M., Pussemier L., Scippo M.L., Van Loco J., Covaci A. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 2012, 50:3725-3740.
21. Giguere V. Transcriptional control of energy homeostasis by the estrogen-related receptors. Endocr. Rev. 2008, 29:677-696.
22. Heckler M.M., Thakor H., Schafer C.C., Riggins R.B. ERK/MAPK regulates ERRgamma expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer. FEBS J. 2014, 281:2431-2442.
23. Hugo E.R., Brandebourg T.D., Woo J.G., Loftus J., Alexander J.W., Ben-Jonathan N. Bisphenol A at environmentally relevant doses inhibits adiponectin release from human adipose tissue explants and adipocytes. Environ. Health Perspect. 2008, 116:1642-1647.
24. Ijichi N., Shigekawa T., Ikeda K., Horie-Inoue K., Fujimura T., Tsuda H., Osaki A., Saeki T., Inoue S. Estrogen-related receptor gamma modulates cell proliferation and estrogen signaling in breast cancer. J. Steroid Biochem. Mol. Biol. 2011, 123:1-7.
25. Kuiper G.G., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., van der Burg B., Gustafsson J.A. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology 1998, 139:4252-4263.
26. Le H.H., Carlson E.M., Chua J.P., Belcher S.M. Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol. Lett. 2008, 176:149-156.
27. Li X., Ying G.G., Zhao J.L., Chen Z.F., Lai H.J., Su H.C. 4-Nonylphenol, bisphenol-A and triclosan levels in human urine of children and students in China, and the effects of drinking these bottled materials on the levels. Environ. Int. 2013, 52:81-86.
28. Marino M., Galluzzo P., Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr. Genomics 2006, 7:497-508.
29. Matsushima A., Kakuta Y., Teramoto T., Koshiba T., Liu X., Okada H., Tokunaga T., Kawabata S., Kimura M., Shimohigashi Y. Structural evidence for endocrine disruptor bisphenol A binding to human nuclear receptor ERR gamma. J. Biochem. 2007, 142:517-524.
30. Okada H., Tokunaga T., Liu X., Takayanagi S., Matsushima A., Shimohigashi Y. Direct evidence revealing structural elements essential for the high binding ability of bisphenol A to human estrogen-related receptor-gamma. Environ. Health Perspect. 2008, 116:32-38.
31. Petrier C., Torres-Palma R., Combet E., Sarantakos G., Baup S., Pulgarin C. Enhanced sonochemical degradation of bisphenol-A by bicarbonate ions. Ultrason. Sonochem. 2010, 17:111-115.
32. Prossnitz E.R., Arterburn J.B., Smith H.O., Oprea T.I., Sklar L.A., Hathaway H.J. Estrogen signaling through the transmembrane G protein-coupled receptor GPR30. Annu. Rev. Physiol. 2008, 70:165-190.
33. Ptak A., Gregoraszczuk E.L. Bisphenol A induces leptin receptor expression, creating more binding sites for leptin, and activates the JAK/Stat, MAPK/ERK and PI3K/Akt signalling pathways in human ovarian cancer cell. Toxicol. Lett. 2012, 210:332-337.
34. Ptak A., Hoffman M., Gruca I., Barc J. Bisphenol A induce ovarian cancer cell migration via the MAPK and PI3K/Akt signalling pathways. Toxicol. Lett. 2014, 229:357-365.
35. Pupo M., Pisano A., Lappano R., Santolla M.F., De Francesco E.M., Abonante S., Rosano C., Maggiolini M. Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts. Environ. Health Perspect. 2012, 120:1177-1182.
36. Razzaque M.A., Masuda N., Maeda Y., Endo Y., Tsukamoto T., Osumi T. Estrogen receptor-related receptor gamma has an exceptionally broad specificity of DNA sequence recognition. Gene 2004, 340:275-282.
37. Rezg R., El-Fazaa S., Gharbi N., Mornagui B. Bisphenol A and human chronic diseases: current evidences, possible mechanisms, and future perspectives. Environ. Int. 2014, 64:83-90.
38. Riggins R.B., Mazzotta M.M., Maniya O.Z., Clarke R. Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response. Endocr. Relat. Cancer 2010, 17:R213-R231.
39. Rubin B.S. Bisphenol A: an endocrine disruptor with widespread exposure and multiple effects. J. Steroid Biochem. Mol. Biol. 2011, 127:27-34.
40. Schiff R., Massarweh S., Shou J., Osborne C.K. Breast cancer endocrine resistance: how growth factor signaling and estrogen receptor coregulators modulate response. Clin. Cancer Res. 2003, 9:447s-454s.
41. Schreiber E., Harshman K., Kemler I., Malipiero U., Schaffner W., Fontana A. Astrocytes and glioblastoma cells express novel octamer-DNA binding proteins distinct from the ubiquitous Oct-1 and B cell type Oct-2 proteins. Nucleic Acids Res. 1990, 18:5495-5503.
42. Sheng Z.G., Zhu B.Z. Low concentrations of bisphenol A induce mouse spermatogonial cell proliferation by G protein-coupled receptor 30 and estrogen receptor-alpha. Environ. Health Perspect. 2011, 119:1775-1780.
43. Sun Y., Wang C., Yang H., Ma X. The effect of estrogen on the proliferation of endometrial cancer cells is mediated by ERRgamma through AKT and ERK1/2. Eur. J. Cancer Prev. 2014, 23:418-424.
44. Suzuki T., Miki Y., Moriya T., Shimada N., Ishida T., Hirakawa H., Ohuchi N., Sasano H. Estrogen-related receptor α in human breast carcinoma as a potent prognostic factor. Cancer Res. 2004, 64:4670-4676.
45. Takeda Y., Liu X., Sumiyoshi M., Matsushima A., Shimohigashi M., Shimohigashi Y. Placenta expressing the greatest quantity of bisphenol A receptor ERR{gamma} among the human reproductive tissues: predominant expression of type-1 ERRgamma isoform. J. Biochem. 2009, 146:113-122.
46. Thomas P., Dong J. Binding and activation of the seven-transmembrane estrogen receptor GPR30 by environmental estrogens: a potential novel mechanism of endocrine disruption. J. Steroid Biochem. Mol. Biol. 2006, 102:175-179.
47. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
48. Vandenberg L.N., Maffini M.V., Sonnenschein C., Rubin B.S., Soto A.M. Bisphenol-A and the great divide: a review of controversies in the field of endocrine disruption. Endocr. Rev. 2009, 30:75-95.
49. vom Saal F.S., Hughes C. An extensive new literature concerning low-dose effects of bisphenol A shows the need for a new risk assessment. Environ. Health Perspect. 2005, 113:926-933.
50. Wan H.T., Leung P.Y., Zhao Y.G., Wei X., Wong M.H., Wong C.K. Blood plasma concentrations of endocrine disrupting chemicals in Hong Kong populations. J. Hazard. Mater. 2013, 261:763-769.
51. Yamamoto T., Mori T., Sawada M., Kuroboshi H., Tatsumi H., Yoshioka T., Matsushima H., Iwasaku K., Kitawaki J. Estrogen-related receptor-gamma regulates estrogen receptor-alpha responsiveness in uterine endometrial cancer. Int. J. Gynecol. Cancer 2012, 22:1509-1516.
52. Zsarnovszky A., Le H.H., Wang H.S., Belcher S.M. Ontogeny of rapid estrogen-mediated extracellular signal-regulated kinase signaling in the rat cerebellar cortex: potent nongenomic agonist and endocrine disrupting activity of the xenoestrogen bisphenol A. Endocrinology 2005, 146:5388-5396.